Importance The US is currently an epicenter of the coronavirus disease 2019 (COVID-19)
pandemic, yet few national data are available on patient characteristics, treatment, and …

Importance Therapies that improve survival in critically ill patients with coronavirus disease
2019 (COVID-19) are needed. Tocilizumab, a monoclonal antibody against the interleukin 6 …

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has brought many unique pathologies, such as …

PURPOSE: This study set out to define the incidence, predictors, and mortality related to
acute renal failure (ARF) and acute renal failure requiring dialysis (ARFD) after coronary …

Background Combination therapy with angiotensin-converting–enzyme (ACE) inhibitors and
angiotensin-receptor blockers (ARBs) decreases proteinuria; however, its safety and effect …

Background B-type natriuretic peptide is released from the cardiac ventricles in response to
increased wall tension. Methods We conducted a prospective study of 1586 patients who …

Cardiac angiography and coronary/vascular interventions depend on iodinated contrast
media and consequently pose the risk of contrast-induced acute kidney injury (AKI). This is an …

Rationale & Objective Underlying kidney disease is an emerging risk factor for more severe
coronavirus disease 2019 (COVID-19) illness. We examined the clinical courses of critically …

Chronic kidney disease1 (CKD) is a worldwide public health problem. In the United States,
there is a rising incidence and prevalence of kidney failure, with poor outcomes and high cost…

The epidemiology of cardiovacular disease risk factors is changing rapidly with the obesity
pandemic. Obesity is independently associated with the risks for coronary heart disease, …